N/A
Completed N=6
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
Breast Cancer · Colon Carcinoma · Malignant Solid Neoplasm · Ovarian carcinoma
Source: ClinicalTrials.gov NCT04902144 ↗
Enrolled (actual)
6
Serious AEs
—
Results posted
Jun 2023
Primary outcomePrimary: Identify Cancer Patients Who Meet Criteria for Genetic Counseling and Testing — 100; 48 patients
Summary
This clinical quality improvement study reviews and develops a clinical operations workflow to identify cancer patients who meet criteria for genetic counseling and testing. This study may improve utilization of genetic counseling and testing amongst community-based oncology providers caring for cancer patients in a rural and underserved area.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Identify Cancer Patients Who Meet Criteria for Genetic Counseling and Testing |
100; 48 | — |
| PRIMARY Uptake of Genetic Testing |
29; 25 | — |
| PRIMARY Clinical and Patient Reported Outcomes Following Genetic Test Results |
2; 3 | — |
Eligibility Criteria
Inclusion Criteria
- Medical oncology providers at OMC who see patients with an active diagnosis of breast, ovarian, prostate, colon, or pancreatic cancer
Exclusion Criteria
- OMC providers who do not see patients with an active diagnosis of cancer
- OMC providers who see patients who are minors
- OMC providers who see patients with precancerous lesions such as ductal carcinoma in situ (the presence of abnormal cells inside a milk duct in the breast) or colon polyps (a small clump of cells that form on the lining of the colon or rectum)
Data sourced from ClinicalTrials.gov (NCT04902144). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.